Accessibility Menu
 
Soligenix logo

Soligenix

(NASDAQ) SNGX

Current Price$1.15
Market Cap$11.54M
Since IPO (1991)-100%
5 Year-100%
1 Year-41%
1 Month-9%

Soligenix Financials at a Glance

Market Cap

$11.54M

Revenue (TTM)

$0.00

Net Income (TTM)

$11.37M

EPS (TTM)

$-2.76

P/E Ratio

-0.41

Dividend

$0.00

Beta (Volatility)

0.45 (Low)

Price

$1.15

Volume

566

Open

$1.13

Previous Close

$1.12

Daily Range

$1.13 - $1.15

52-Week Range

$1.00 - $6.23

SNGX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Soligenix

Industry

Biotechnology

Employees

14

CEO

Christopher J. Schaber, PhD

Headquarters

Princeton, NJ 08540, US

SNGX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-242%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-2.44%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.54M

Shares Outstanding

10.31M

Volume

566

Short Interest

0.00%

Avg. Volume

223.44K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$11.85M

EBITDA

$11.85M

Operating Cash Flow

$10.27M

Capital Expenditure

$5.88K

Free Cash Flow

$10.27M

Cash & ST Invst.

$7.94M

Total Debt

$358.14K

Soligenix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$11.54M

N/A

Market Cap/Employee

$824.49K

N/A

Employees

14

N/A

Net Income

$2.90M

+3.1%

EBITDA

$3.47M

+6.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$7.58M

+19.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$244.12K

N/A

Short Term Debt

$114.02K

-92.3%

Return on Assets

-1.23%

N/A

Return on Invested Capital

-2.19%

N/A

Free Cash Flow

$2.74M

-22.8%

Operating Cash Flow

$2.75M

-22.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VYNEVYNE Therapeutics Inc.
$0.61-0.64%
KZIAKazia Therapeutics Limited
$8.99+1.93%
QLGNQualigen Therapeutics, Inc.
$3.21+5.59%
XBIOXenetic Biosciences, Inc.
$3.02-1.31%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$64.78+0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.77+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.48+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$49.91+0.02%

Questions About SNGX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.